Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Feb;17(2):CR104-9.
doi: 10.12659/msm.881395.

PSA mass as a marker of prostate cancer progression after radical prostatectomy

Piotr Bryniarski  1 , Andrzej Paradysz, Mieczyslaw Fryczkowski
Affiliations

PSA mass as a marker of prostate cancer progression after radical prostatectomy

Piotr Bryniarski et al. Med Sci Monit. 2011 Feb.

Abstract

Background: Obese patients with prostate cancer may have lower preoperative PSA concentration due to hemodilution. Lower PSA concentration may falsely affect assessing the risk of progression after radical prostatectomy (RP). The aim of this study was to determine preoperative PSA mass as the absolute amount of PSA protein secreted into circulation, and evaluation of its usefulness in prediction of biochemical recurrence after RP.

Material/methods: 177 patients after RP due to prostate cancer were included in the study. On the basis of formulas, PSA mass was calculated {PSA mass [µg] = (weight [kg])0.425 × (height [cm])0.72 × 0.007184 × 1.670 × PSA concentration [ng/ml]}. Patients were divided into 3 groups according to increasing values of PSA mass. The following features were assessed and compared between these groups (χ-square test): pathologic stage T3, nodal metastases, positive surgical margins, biochemical and local recurrence and the rate of death. Cancer-specific survival was assessed depending on PSA mass (Kaplan-Meier curves with log rank test). The usefulness of PSA mass in prediction of biochemical recurrence was compared with PSA concentration (logistic regression with ROC curves).

Results: Pathologic stage T3, nodal metastases, positive surgical margins and progression were more common in patients with higher levels of PSA mass (p<0.01). Cancer-specific survival was significantly shorter in patients with elevated values of PSA mass (p=0.02). Preoperative PSA mass was a more sensitive predictor of biochemical recurrence than was PSA concentration (p=0.04).

Conclusions: The preoperative PSA mass is a better predictor of biochemical recurrence after RP than PSA concentration.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Kaplan-Meier analysis of cancer-specific survival in two groups of patients with high (≥70 μg) and low (<70 μg) values of PSA mass (I and II PSA mass groups combined due to lack of uncensored cases in group I) (log-rank test; p=0.02)
Figure 2
Figure 2
The comparison of two ROC curves of models predicting biochemical recurrence after RP (p=0.04).
See this image and copyright information in PMC

References

    1. Kattan MW, Wheeler TM, Scardino PT. Postoperative nomogram for disease recurrence after radical prostatectomy for prostate cancer. J Clin Oncol. 1999;17:1499–507. - PubMed
    1. Kattan MW, Eastham JA, Stapleton AMF, et al. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst. 1998;90:766–71. - PubMed
    1. Bañez LL, Hamilton RJ, Partin AW, et al. Obesity-related plasma hemodilution and PSA concentration among men with prostate cancer. JAMA. 2007;298:2275–80. - PubMed
    1. Vollmer RT, Humphrey PA. Tumor volume in prostate cancer and serum prostate-specific antigen: analysis from a kinetic viewpoint. Am J Clin Pathol. 2003;119:80–89. - PubMed
    1. Boer P. Estimated lean body mass as an index for normalization of body fluid volumes in humans. Am J Physiol. 1984;247:632–36. - PubMed

Substances